Oxycodone drugs market to reach $8.07 billion by 2030 at 6.1% cagr, driven by rising burden of orthopedic disorders and chronic pain conditions.
Read MoreOral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read More
RNA targeting small molecule drug discovery market to reach $6.04 billion by 2030 at 23.5% CAGR, driven by increasing prevalence of cancer, genetic disorders, and viral infections.
Read More
Rituximab Biosimilars Sector Forecast Shows Robust Momentum, Climbing to $6.26 Billion With 13% CAGR
Rituximab biosimilars market to reach $6.26 billion by 2030 at 13.0% CAGR, driven by rising prevalence of non-hodgkins lymphoma and autoimmune diseases.
Read More
Risperidone market to reach $11.13 billion by 2030 at 7.6% CAGR, driven by increasing prevalence of mental health disorders.
Read More
Ribonucleic acid interference technology market to reach $9.19 billion by 2030 at 15.6% CAGR, driven by increasing demand for targeted therapeutics.
Read More
Ribonucleic acid based oncolytic therapy market to reach $4.94 billion by 2030 at 18.4% CAGR, driven by growing adoption of personalized medicine.
Read More
Ribonucleic acid therapy clinical trials market to reach $3.4 billion by 2030 at 4.7% CAGR, driven by increasing burden of infectious diseases.
Read More
The global ribonucleic acid editing market to reach $26.48 billion by 2030 at 8.5% CAGR, driven by rise of genetic disorders.
Read More
Rhinovirus infections drug market to reach $2.05 billion by 2030 at 8.6% CAGR, driven by increasing incidence of respiratory disorders.
Read More